David R. Glover

400 total citations
18 papers, 311 citations indexed

About

David R. Glover is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, David R. Glover has authored 18 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 4 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in David R. Glover's work include Blood Pressure and Hypertension Studies (6 papers), Heart Failure Treatment and Management (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). David R. Glover is often cited by papers focused on Blood Pressure and Hypertension Studies (6 papers), Heart Failure Treatment and Management (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). David R. Glover collaborates with scholars based in United Kingdom, Ireland and United States. David R. Glover's co-authors include W A Littler, T. J. Stallard, W. A. Littler, R.G. Murray, John McCafferty, C. S. Robinson, C G Wathen, M C Petch, A L Muir and Joseph De Giovanni and has published in prestigious journals such as European Heart Journal, American Heart Journal and Current Opinion in Structural Biology.

In The Last Decade

David R. Glover

16 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David R. Glover United Kingdom	10	248	64	42	34	33	18	311
Shmuel Oren United States	13	257 1.0×	66 1.0×	44 1.0×	34 1.0×	51 1.5×	23	377
Devereux Rb United States	10	364 1.5×	56 0.9×	52 1.2×	28 0.8×	59 1.8×	17	399
Fawaz Akhras United Kingdom	12	239 1.0×	68 1.1×	84 2.0×	19 0.6×	23 0.7×	25	332
Saktipada Mookherjee United States	10	238 1.0×	63 1.0×	45 1.1×	23 0.7×	28 0.8×	23	347
James Blake New Zealand	8	267 1.1×	54 0.8×	47 1.1×	18 0.5×	39 1.2×	28	330
E Sivertssen Norway	11	232 0.9×	105 1.6×	46 1.1×	10 0.3×	30 0.9×	56	362
Peter Sleight United Kingdom	9	338 1.4×	87 1.4×	30 0.7×	22 0.6×	36 1.1×	11	462
Jean Delonca France	12	287 1.2×	55 0.9×	89 2.1×	12 0.4×	52 1.6×	22	362
Leonidas Poulimenos Greece	11	274 1.1×	59 0.9×	61 1.5×	23 0.7×	34 1.0×	43	359
William S. Frankl United States	15	405 1.6×	138 2.2×	46 1.1×	25 0.7×	9 0.3×	47	521

Countries citing papers authored by David R. Glover

Since Specialization

Citations

This map shows the geographic impact of David R. Glover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Glover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Glover more than expected).

Fields of papers citing papers by David R. Glover

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Glover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Glover. The network helps show where David R. Glover may publish in the future.

Co-authorship network of co-authors of David R. Glover

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Glover. A scholar is included among the top collaborators of David R. Glover based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Glover. David R. Glover is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

McCafferty, John & David R. Glover. (2000). Engineering therapeutic proteins. Current Opinion in Structural Biology. 10(4). 417–420. 16 indexed citations

Glover, David R., et al.. (1990). Overview of clinical trials of dilevalol in essential hypertension.. PubMed. 4 Suppl 2. 49–53. 3 indexed citations

Bain, R.J.I., David R. Glover, W. A. Littler, & A. M. Geddes. (1988). The impact of a policy of collaborative management on mortality and morbidity from infective endocarditis. International Journal of Cardiology. 19(1). 47–54. 9 indexed citations

Glover, David R., et al.. (1988). Symptoms in hypertensive patients. Journal of Hypertension. 6(4). S629–630. 8 indexed citations

Ghosh, Asim Kumar, et al.. (1987). A single-blind, comparative study of hydrochlorothiazidel amiloride (‘Moduret’ 25) and hydrochlorothiazide/triamterene (‘Dyazide’) in elderly patients with congestive heart failure. Current Medical Research and Opinion. 10(9). 573–579. 5 indexed citations

Donohoe, J., et al.. (1987). Lisinopril Treatment of Hypertension in Patients with Impaired Renal Function. Gerontology. 33(s1). 36–41.

Glover, David R. & W A Littler. (1987). Factors influencing survival and mode of death in severe chronic ischaemic cardiac failure.. Heart. 57(2). 125–132. 41 indexed citations

Wathen, C G, et al.. (1987). Effect of the partial beta-agonist prenalterol on plasma renin activity in patients with left ventricular failure. Clinica Chimica Acta. 162(1). 97–100. 3 indexed citations

Glover, David R., et al.. (1987). Influence of Age on Blood Pressure Response to Enalapril. Gerontology. 33(s1). 48–54. 7 indexed citations

10.

Glover, David R., C G Wathen, R.G. Murray, et al.. (1985). Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo.. Heart. 53(2). 208–215. 23 indexed citations

11.

Littler, W A, et al.. (1985). Regression of Left Ventricular Hypertrophy in Hypertension. Journal of Cardiovascular Pharmacology. 7. S52–S55. 31 indexed citations

12.

Glover, David R., et al.. (1984). Once daily indapamide in the treatment of the elderly and young hypertensive. European Journal of Clinical Pharmacology. 27(4). 397–405. 6 indexed citations

13.

Watson, R. Douglas, David R. Glover, A Page, et al.. (1984). The birmingham trial of permanent pacing in patients with intraventricular conduction disorders after acute myocardial infarction. American Heart Journal. 108(3). 496–501. 14 indexed citations

14.

Glover, David R., et al.. (1984). Coronary artery disease in Asians in Birmingham.. Heart. 52(6). 610–613. 34 indexed citations

15.

Glover, David R., C. S. Robinson, & R.G. Murray. (1984). Diagnostic exercise testing in 104 patients over 65 years of age. European Heart Journal. 5(suppl E). 59–62. 25 indexed citations

16.

Glover, David R., et al.. (1983). Thepattern andseverity ofcoronary artery disease inAsians andwhites living inBirmingham.

17.

Glover, David R., et al.. (1983). The pattern and severity of coronary artery disease in Asians and whites living in Birmingham. Postgraduate Medical Journal. 59(696). 634–635. 9 indexed citations

18.

Glover, David R., et al.. (1981). The Relationship between Ambulatory Blood Pressure and Echocardiographically Assessed Left Ventricular Hypertrophy. Clinical Science. 61(s7). 101s–103s. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact